Department of Planning and BudgetAn official website of the Commonwealth of Virginia Here's how you knowAn official websiteHere's how you know

Virginia Regulatory Town Hall
Agency
Virginia Department of Health
Guidance Document Information
Title Guidelines for the Use of Isoniazid/Rifapentine for Treatment of Latent TB Infection in Health Department Settings
Document ID EPI-411
Summary Provides guidance on the use of the isoniazid/rifapentine regimen for the treatment of latent tuberculosis infection. (Last review 12/2015)
Effective Date 10/1/2012
pdf View document text     Posted On 12/30/2015                 Document on Town Hall
Explanation or Citations Based on guidance from Centers for Disease Control and Prevention. Recommendations for Use of an Isoniazid-Rifapentine Regimen with Direct Observation to Treat Latent Mycobacterium tuberculosis Infection. MMWR 2011;60:1650-1653. http://www.cdc.gov/mmwr/pdf/wk/mmy6048.pdf

This document applies to the following chapters
[12 VAC 5-90] Regulations for Disease Reporting and Control


Back to showing guidance documents for this board

Back to showing guidance documents for this agency